| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX001 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 34.0 mg/kg/injection | 92.0 | Antitumor endpoint evaluated on day 12; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 68.0 mg/kg/injection | 134.0 | Antitumor endpoint evaluated on day 12; 08/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX001 (ip) | mean tumor weight | carboxymethylcellulose (CMC) | 135.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 12; 06/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 3.12 mg/kg/injection | 103.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 6.25 mg/kg/injection | 83.0 | Antitumor endpoint evaluated on day 14; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 12.5 mg/kg/injection | 88.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 12.5 mg/kg/injection | 74.0 | Antitumor endpoint evaluated on day 20; 07/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 12.5 mg/kg/injection | 77.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 18.3 mg/kg/injection | 61.0 | Antitumor endpoint evaluated on day 14; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 18.3 mg/kg/injection | 87.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 18.3 mg/kg/injection | 35.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 18.7 mg/kg/injection | 45.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 74.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 69.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 00/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 25.0 mg/kg/injection | 77.0 | Antitumor endpoint evaluated on day 20; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 37.5 mg/kg/injection | 53.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 37.5 mg/kg/injection | 62.0 | Antitumor endpoint evaluated on day 14; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 37.5 mg/kg/injection | 34.0 | Antitumor endpoint evaluated on day 14; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 37.5 mg/kg/injection | 71.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 61.0 | Antitumor endpoint evaluated on day 14; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 04/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 00/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 50.0 mg/kg/injection | 101.0 | Antitumor endpoint evaluated on day 20; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 75.0 mg/kg/injection | 31.0 | Antitumor endpoint evaluated on day 14; 09/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 75.0 mg/kg/injection | 5.0 | Antitumor endpoint evaluated on day 14; 07/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 75.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 14; 01/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 75.0 mg/kg/injection | 49.0 | Antitumor endpoint evaluated on day 14; 08/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 00/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 100.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 20; 04/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 150.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 14; 00/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | mean tumor weight | other | 300.0 mg/kg/injection | 0.0 | Antitumor endpoint evaluated on day 14; 00/10 animals surviving on tox evaluation day (usually day 5) |